Zhenzhou Shen - Concepedia

Author

Zhenzhou Shen

Also Known As

Bu Hong, Hong Bu, S. Zhen-zhou, S. Zhenzhou, Shen Z, Shen Zhenzhou, Z Z Shen, Zhen-Zhou Shen, Zhen-zhou Shen, Zhenzhou SHEN

111

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Fudan University Shanghai Cancer Center Shanghai Medical College of Fudan University Fudan University Sun Yat-sen University Obstetrics and Gynecology Hospital of Fudan University

About

Zhenzhou Shen is an author at Fudan University Shanghai Cancer Center specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	1.6K
2	Health Sciences	2	2	60
3	Biostatistics	1	1	72
4	Cell Biology	1	1	310
5	Epidemiology	1	1	40

Zhenzhou Shen

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial Luca Gianni, Urania Dafni, Richard D. Gelber, The Lancet Oncology Breast OncologyOncologyAdjuvant ChemotherapyBreast Cancer4-Year Follow-up	2011	611
Curcumin exerts multiple suppressive effects on human breast carcinoma cells Zhi‐Ming Shao, Zhenzhou Shen, Canhui Liu, International Journal of Cancer Tumor BiologyBreast OncologyOncologyChemoprevention StrategyEndocrine-related Cancer	2001	310
Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer Ke‐Da Yu, Fu-Gui Ye, Min He, JAMA Oncology	2020	201
Identification of breast cancer metastasis‐associated proteins in an isogenic tumor metastasis model using two‐dimensional gel electrophoresis and liquid chromatography‐ion trap‐mass spectrometry Da‐Qiang Li, Lei Wang, Fei Fei, PROTEOMICS	2006	146
Randomized Trial of Lapatinib Versus Placebo Added to Paclitaxel in the Treatment of Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancer Zhongzhen Guan, Binghe Xu, Michelle DeSilvio, Journal of Clinical Oncology	2013	139
Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy Ou Huang, Liping Wang, Kunwei Shen, Breast Cancer Research and Treatment Surgical OncologyBreast OncologyExtended Radical MastectomyMedicineCancer Management	2007	136
The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives A‐Yong Cao, Juan Huang, Zhen Hu, Breast Cancer Research and Treatment Breast OncologyOncologyCancer EpidemiologyPalb2 Germline MutationsSomatic Variant	2008	90
Predicting sentinel lymph node metastasis in a Chinese breast cancer population: assessment of an existing nomogram and a new predictive nomogram Jiaying Chen, Jiajian Chen, Benlong Yang, Breast Cancer Research and Treatment Breast OncologyCancer DetectionMedicineBreast ImagingCancer Registration	2012	72
Outcome of Pure Mucinous Breast Carcinoma Compared to Infiltrating Ductal Carcinoma: A Population-based Study from China A‐Yong Cao, Min He, Zhe-Bin Liu, Annals of Surgical Oncology Infiltrating Ductal CarcinomaSurgical OncologyPopulation-based StudyBreast OncologyMedicine	2012	60
Identification of a Comprehensive Spectrum of Genetic Factors for Hereditary Breast Cancer in a Chinese Population by Next-Generation Sequencing Xiaochen Yang, Jiong Wu, Jingsong Lu, PLoS ONE Breast OncologySomatic VariantHealth SciencesTumor HeterogeneityMedicine	2015	47

Page 1